These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 19270786)
1. Medications as a potential source of exposure to phthalates in the U.S. population. Hernández-Díaz S; Mitchell AA; Kelley KE; Calafat AM; Hauser R Environ Health Perspect; 2009 Feb; 117(2):185-9. PubMed ID: 19270786 [TBL] [Abstract][Full Text] [Related]
2. Medications as a potential source of exposure to phthalates among women of childbearing age. Hernández-Díaz S; Su YC; Mitchell AA; Kelley KE; Calafat AM; Hauser R Reprod Toxicol; 2013 Jun; 37():1-5. PubMed ID: 23333816 [TBL] [Abstract][Full Text] [Related]
3. Medications as a source of human exposure to phthalates. Hauser R; Duty S; Godfrey-Bailey L; Calafat AM Environ Health Perspect; 2004 May; 112(6):751-3. PubMed ID: 15121520 [TBL] [Abstract][Full Text] [Related]
4. Identification of phthalates in medications and dietary supplement formulations in the United States and Canada. Kelley KE; Hernández-Díaz S; Chaplin EL; Hauser R; Mitchell AA Environ Health Perspect; 2012 Mar; 120(3):379-84. PubMed ID: 22169271 [TBL] [Abstract][Full Text] [Related]
5. Prenatal exposures to phthalates among women in New York City and Krakow, Poland. Adibi JJ; Perera FP; Jedrychowski W; Camann DE; Barr D; Jacek R; Whyatt RM Environ Health Perspect; 2003 Nov; 111(14):1719-22. PubMed ID: 14594621 [TBL] [Abstract][Full Text] [Related]
6. Identifying sources of phthalate exposure with human biomonitoring: results of a 48h fasting study with urine collection and personal activity patterns. Koch HM; Lorber M; Christensen KL; Pälmke C; Koslitz S; Brüning T Int J Hyg Environ Health; 2013 Nov; 216(6):672-81. PubMed ID: 23333758 [TBL] [Abstract][Full Text] [Related]
7. Use of dietary supplements in relation to urinary phthalate metabolite concentrations: Results from the National Health and Nutrition Examination Survey. Romano ME; O'Connell K; Du M; Rehm CD; Kantor ED Environ Res; 2019 May; 172():437-443. PubMed ID: 30826666 [TBL] [Abstract][Full Text] [Related]
8. Cumulative exposure to phthalates from phthalate-containing drug products: a Danish population-wide study. Ennis ZN; Broe A; Pottegård A; Ahern TP; Hallas J; Damkier P Br J Clin Pharmacol; 2018 Aug; 84(8):1798-1805. PubMed ID: 29688578 [TBL] [Abstract][Full Text] [Related]
9. Exposure assessment issues in epidemiology studies of phthalates. Johns LE; Cooper GS; Galizia A; Meeker JD Environ Int; 2015 Dec; 85():27-39. PubMed ID: 26313703 [TBL] [Abstract][Full Text] [Related]
10. Urinary concentrations of phthalates and phenols in a population of Spanish pregnant women and children. Casas L; Fernández MF; Llop S; Guxens M; Ballester F; Olea N; Irurzun MB; Rodríguez LS; Riaño I; Tardón A; Vrijheid M; Calafat AM; Sunyer J; Environ Int; 2011 Jul; 37(5):858-66. PubMed ID: 21440302 [TBL] [Abstract][Full Text] [Related]
11. Vaginal douching and racial/ethnic disparities in phthalates exposures among reproductive-aged women: National Health and Nutrition Examination Survey 2001-2004. Branch F; Woodruff TJ; Mitro SD; Zota AR Environ Health; 2015 Jul; 14():57. PubMed ID: 26174070 [TBL] [Abstract][Full Text] [Related]
12. Increased risk of phthalates exposure for recurrent pregnancy loss in reproductive-aged women. Liao KW; Kuo PL; Huang HB; Chang JW; Chiang HC; Huang PC Environ Pollut; 2018 Oct; 241():969-977. PubMed ID: 30029331 [TBL] [Abstract][Full Text] [Related]
13. Occurrence of phthalate metabolites in human urine from several Asian countries. Guo Y; Alomirah H; Cho HS; Minh TB; Mohd MA; Nakata H; Kannan K Environ Sci Technol; 2011 Apr; 45(7):3138-44. PubMed ID: 21395215 [TBL] [Abstract][Full Text] [Related]
14. Temporal trends of phthalate exposures during 2007-2010 in Swedish pregnant women. Shu H; Jönsson BA; Gennings C; Svensson Å; Nånberg E; Lindh CH; Knutz M; Takaro TK; Bornehag CG J Expo Sci Environ Epidemiol; 2018 Sep; 28(5):437-447. PubMed ID: 29472621 [TBL] [Abstract][Full Text] [Related]
15. Levels of seven urinary phthalate metabolites in a human reference population. Blount BC; Silva MJ; Caudill SP; Needham LL; Pirkle JL; Sampson EJ; Lucier GW; Jackson RJ; Brock JW Environ Health Perspect; 2000 Oct; 108(10):979-82. PubMed ID: 11049818 [TBL] [Abstract][Full Text] [Related]
16. Phthalate metabolites in obese individuals undergoing weight loss: Urinary levels and estimation of the phthalates daily intake. Dirtu AC; Geens T; Dirinck E; Malarvannan G; Neels H; Van Gaal L; Jorens PG; Covaci A Environ Int; 2013 Sep; 59():344-53. PubMed ID: 23892227 [TBL] [Abstract][Full Text] [Related]
17. Determinants of exposure levels, metabolism, and health risks of phthalates among pregnant women in Wuhan, China. Li J; Qian X; Zhao H; Zhou Y; Xu S; Li Y; Xiang L; Shi J; Xia W; Cai Z Ecotoxicol Environ Saf; 2019 Nov; 184():109657. PubMed ID: 31526923 [TBL] [Abstract][Full Text] [Related]
18. Human biomonitoring of phthalate exposure in Austrian children and adults and cumulative risk assessment. Hartmann C; Uhl M; Weiss S; Koch HM; Scharf S; König J Int J Hyg Environ Health; 2015 Jul; 218(5):489-99. PubMed ID: 25959523 [TBL] [Abstract][Full Text] [Related]
19. [Cumulative risk assessment of phthalates exposure in preschool children]. Gao H; Huang K; Wu XY; Cai XX; Han Y; Zhu P; Hao JH; Tao FB Zhonghua Liu Xing Bing Xue Za Zhi; 2019 May; 40(5):585-589. PubMed ID: 31177743 [No Abstract] [Full Text] [Related]
20. Phthalate exposure among pregnant women in Jerusalem, Israel: results of a pilot study. Berman T; Hochner-Celnikier D; Calafat AM; Needham LL; Amitai Y; Wormser U; Richter E Environ Int; 2009 Feb; 35(2):353-7. PubMed ID: 18824263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]